MetaTOC stay on top of your field, easily

The association between anti-acid use and tyrosine kinase inhibitor–induced hepatotoxicity

, , ,

Journal of Oncology Pharmacy Practice

Published online on

Abstract

Journal of Oncology Pharmacy Practice, Ahead of Print.
Objective: This study aimed to investigate changes in hepatotoxicity associated with the concomitant use of tyrosine kinase inhibitors (TKIs) with Acid suppressants (AS), and to explain the underlying mechanisms. Data Sources: The PubMed, Scopus and Web ...